Elisabeth R. Seyferth, MD (she/her/hers)

Integrated IR Resident
Hospital of the University of Pennsylvania

Presentation(s):

• High-Throughput Drug Screening of Patient-Derived Cell Lines Identifies Novel Potential Treatment Options for Hepatocellular Carcinoma

  Wednesday, March 8, 2023
  3:45 PM – 3:54 PM

  Disclosure(s): No financial relationships to disclose